Tag: DSM

In for a Penny, In for a Pound: The Advanced Bioeconomy and all the pivots

In for a Penny, In for a Pound: The Advanced Bioeconomy and all the pivots

December 28, 2017 |

It’s been such a busy cycle in the bioeconomy that we are well overdue for a shout-out to a pal of the Digest, Henry Threadgill, for winning a Pulitzer Prize for his landmark composition, In for a Penny, In for a Pound. Threadgill’s masterpiece (which you can experience here) comes to mind as news arrives […]

Read More

Fuels America leaders say “thank you, President Trump” for RFS support

Fuels America leaders say “thank you, President Trump” for RFS support

November 10, 2017 |

In Washington, a coalition of the nation’s leaders in advanced and cellulosic biofuels thanked President Trump for his commitment to the RFS, which “has attracted billions of dollars of investment in first-of-a-kind technologies in the advanced and cellulosic biofuels industry.” They also express concerns about the EPA’s July proposal to reduce White House-approved growth in […]

Read More

Amyris enters first production development and production agreement with DSM

Amyris enters first production development and production agreement with DSM

July 17, 2017 |

In California, Amyris announce it has entered into its first product development and production agreement with Koninklijke DSM N.V. (Royal DSM), the global science-based company active in health, nutrition and materials, to develop a food and nutrition molecule for which DSM is a major market provider. As part of the previously announced equity investment DSM […]

Read More

DSM invests $25 million in Amyris

DSM invests $25 million in Amyris

May 8, 2017 |

In California, Amyris, Inc. the industrial bioscience company, and Koninklijke DSM N.V., the global science-based company active in health, nutrition and materials, announced that they have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health […]

Read More

Strategic Intent: The Digest’s 2017 Multi-Slide Guide to DSM in the advanced bioeconomy

Strategic Intent: The Digest’s 2017 Multi-Slide Guide to DSM in the advanced bioeconomy

May 8, 2017 |

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such […]

Read More

DSM invests in Amyris

DSM invests in Amyris

May 8, 2017 |

In California, DSM led a round of investors that will put up to $95 million in equity financing into Amyris via a registered direct offering of convertible preferred stock, and private placements of convertible preferred stock and warrants. Amyris is in the process of reducing its debt by approximately $75 million. DSM has agreed to […]

Read More

Strategic Intent: The Digest’s 2016 Multi-Slide Guide to DSM in the advanced bioeconomy

Strategic Intent: The Digest’s 2016 Multi-Slide Guide to DSM in the advanced bioeconomy

September 1, 2016 |

This season, The Digest is hosting the Strategic Intent webinar series, looking at the plans, progress and future milestones of strategic stakeholders in the Advanced Bioeconomy. In this slide deck, we looked at DSM and its direct investments, partnerships and alliances with companies both heralded and unknown.

Read More

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

Consolidation! Dyadic sells industrial technology biz to DuPont for $75M

November 11, 2015 |

As Dyadic cashes out of industrial biotech and retains a C1 license for pharma, DSM and Syngenta also announce a partnership. Companies are girding their loins for the long haul. The Digest takes a look, In Florida, DuPont Industrial Biosciences will acquire substantially all of the enzyme and technology assets Dyadic’s Industrial Technology business for $75 […]

Read More

DSM, KLM rank high in annual Dow Jones Sustainability Index 

DSM, KLM rank high in annual Dow Jones Sustainability Index 

September 13, 2015 |

In the Netherlands, Air France-KLM has been listed as No. 1 in the airline industry on the Dow Jones Sustainability Index, the most important international index assessing the performance of the leading sustainability-driven companies worldwide. Additionally, for the 7th consecutive year, Air France-KLM has maintained its position as Industry Group Leader in the broader transportation […]

Read More

DSM, CVC partnership for Polymer Intermediates, Composite Resins finalizes, changes shape of nylon industry

DSM, CVC partnership for Polymer Intermediates, Composite Resins finalizes, changes shape of nylon industry

August 2, 2015 |

In the Netherlands, DSM and CVC Capital Partners (CVC) have finalized the formation of ChemicaInvest B.V. for Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins. DSM contributed its global caprolactam business (Europe, North America, its 60% stake in DNCC (China) and the caprolactam licensing business), acrylonitrile business and composite resins business including its 75% stake […]

Read More